115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12609)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39031)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival of patients with microsatellite instability-high and Lynch syndrome-associated pancreatic ductal adenocarcinomas
    Meeting Abstract

    Nasar, N.; Eikenboom, E.; Seier, K.; Gonen, M.; Wagner, A.; Jarnagin, W. R.; Drebin, J. A.; D'Angelica, M. I.; Kingham, T. P.; Balachandran, V. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • ARC-8: Phase 1/1b randomized study of quemliclustat + gemcitabine/nab-paclitaxel ± zimberelimab in patients with treatment-naive metastatic pancreatic adenocarcinoma
    Meeting Abstract

    Wainberg, Z. A.; Manji, G. A.; Bahary, N.; Ulahannan, S. V.; Pant, S.; Uboha, N. V.; Oberstein, P. E.; Lu, L. H.; Scott, J. R.; Wu, W.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Salvage hepatic artery infusion chemotherapy after first-line systemic failure in patients with unresectable cholangiocarcinoma
    Meeting Abstract

    Nasar, N.; Armstrong, M.; Chou, J. F.; Gonen, M.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; Kingham, T. P.; Wei, A. C. C.; D'Angelica, M. I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Extrahepatic cholangiocarcinoma: Genomic variables associated with anatomical location and outcome
    Meeting Abstract

    Preston, W. A.; Drill, E. N.; Boerner, T.; Harding, J. J.; Cercek, A.; O'Reilly, E. M.; Abou-Alfa, G. K.; Park, W.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • PROOF 301: Results of an early discontinued randomized phase 3 trial of the oral FGFR inhibitor infigratinib vs. gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma (CCA) with an FGFR2 gene fusion/rearrangement
    Meeting Abstract

    Abou-Alfa, G. K.; Borbath, I.; Roychowdhury, S.; Goyal, L.; Lamarca, A.; Macarulla, T.; Shroff, R. T.; Oh, D. Y.; Javle, M. M.; Tamas, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Patient-derived biliary tract cancer organoid biobank: Is personalized medicine utilizing organoids feasible for patients with cholangiocarcinoma?
    Meeting Abstract

    Nasar, N.; McIntyre, S. M. H.; Kalvin, H. L.; Gonen, M.; Lecomte, N.; Karnoub, E.; Hong, J.; Soares, K.; Balachandran, V. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Has management of locally advanced intrahepatic cholangiocarcinoma evolved with the evidence? Trends and practice patterns from the National Cancer Database
    Meeting Abstract

    Schleimer, L. E.; Kalvin, H. L.; Kingham, T. P.; Soares, K.; D'Angelica, M. I.; Balachandran, V. P.; Drebin, J. A.; Cercek, A.; Abou-Alfa, G. K.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial
    Meeting Abstract

    Botta, G. P.; Kelly, R. J.; Jin, Z.; Ma, H.; Ku, G. Y.; Zhao, D.; Mehta, R.; Carnevale, J. C.; Sierra, G.; Jia, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS
    Meeting Abstract

    Cytryn, S. L.; Phu, W.; Shah, R. H.; Walch, H. S.; Chatila, W. K.; Vakiani, E.; Brannon, A. R.; Ladanyi, M.; Srivastava, A.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save